INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

Pomerantz LLP is investigating potential securities fraud claims against Teladoc Health following the company's significant revenue guidance downgrade on July 29, 2026. Teladoc reduced its full-year 2026 revenue guidance from $2.48-$2.58 billion to $2.36-$2.45 billion, citing uncertainties in cash pay and business model transition. The announcement triggered a 38.32% stock price decline, falling $2.60 per share to $6.58.